(USFD) US Foods Holding - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US9120081099
Stock: Food Products, Non-Food Products, Distribution, Software
Total Rating 55
Risk 71
Buy Signal 0.70
| Risk 5d forecast | |
|---|---|
| Volatility | 24.9% |
| Relative Tail Risk | -11.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.20 |
| Alpha | 22.60 |
| Character TTM | |
|---|---|
| Beta | 0.938 |
| Beta Downside | 1.260 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.01% |
| CAGR/Max DD | 1.97 |
EPS (Earnings per Share)
Revenue
Description: USFD US Foods Holding March 05, 2026
US Foods Holding Corp. (USFD) distributes food and non-food products to foodservice customers across the United States. This includes fresh, frozen, and dry goods. The company also offers MOXe, a foodservice business application.
USFD serves a diverse customer base. This includes independent restaurants, national chains, healthcare facilities, hospitality venues, educational institutions, and government entities. Food distribution is a low-margin, high-volume business.
The company, incorporated in 2007 and headquartered in Rosemont, Illinois, changed its name from USF Holding Corp. in 2016. Understanding these operational details can help refine your research on ValueRay.
Headlines to watch out for
- Restaurant industry health dictates foodservice demand
- Fuel price volatility impacts distribution costs
- Labor shortages increase operational expenses
- MOXe adoption expands technology revenue
- Food commodity prices affect product margins
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 676.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.50 > 1.0 |
| NWC/Revenue: 1.45% < 20% (prev 1.79%; Δ -0.34% < -1%) |
| CFO/TA 0.10 > 3% & CFO 1.37b > Net Income 676.0m |
| Net Debt (5.99b) to EBITDA (1.75b): 3.43 < 3 |
| Current Ratio: 1.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (225.1m) vs 12m ago -4.52% < -2% |
| Gross Margin: 17.41% > 18% (prev 0.17%; Δ 1.72k% > 0.5%) |
| Asset Turnover: 284.2% > 50% (prev 281.9%; Δ 2.25% > 0%) |
| Interest Coverage Ratio: 4.22 > 6 (EBITDA TTM 1.75b / Interest Expense TTM 305.0m) |
Altman Z'' 1.78
| A: 0.04 (Total Current Assets 4.16b - Total Current Liabilities 3.59b) / Total Assets 14.31b |
| B: 0.19 (Retained Earnings 2.68b / Total Assets 14.31b) |
| C: 0.09 (EBIT TTM 1.29b / Avg Total Assets 13.87b) |
| D: 0.27 (Book Value of Equity 2.73b / Total Liabilities 10.01b) |
| Altman-Z'' Score: 1.78 = BBB |
Beneish M -3.07
| DSRI: 1.02 (Receivables 2.26b/2.12b, Revenue 39.42b/37.88b) |
| GMI: 0.99 (GM 17.41% / 17.25%) |
| AQI: 0.95 (AQ_t 0.50 / AQ_t-1 0.53) |
| SGI: 1.04 (Revenue 39.42b / 37.88b) |
| TATA: -0.05 (NI 676.0m - CFO 1.37b) / TA 14.31b) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of USFD shares?
As of March 15, 2026, the stock is trading at USD 91.34 with a total of 1,966,147 shares traded.
Over the past week, the price has changed by +4.90%, over one month by -5.30%, over three months by +24.19% and over the past year by +48.60%.
Over the past week, the price has changed by +4.90%, over one month by -5.30%, over three months by +24.19% and over the past year by +48.60%.
Is USFD a buy, sell or hold?
US Foods Holding has received a consensus analysts rating of 4.47.
Therefore, it is recommended to buy USFD.
- StrongBuy: 10
- Buy: 5
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the USFD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 110.2 | 20.6% |
| Analysts Target Price | 110.2 | 20.6% |
USFD Fundamental Data Overview March 12, 2026
P/E Trailing = 30.9014
P/E Forward = 19.0476
P/S = 0.5138
P/B = 4.652
P/EG = 0.2439
Revenue TTM = 39.42b USD
EBIT TTM = 1.29b USD
EBITDA TTM = 1.75b USD
Long Term Debt = 5.06b USD (from longTermDebt, last quarter)
Short Term Debt = 353.0m USD (from shortTermDebt, last quarter)
Debt = 6.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.99b USD (from netDebt column, last quarter)
Enterprise Value = 26.24b USD (20.25b + Debt 6.03b - CCE 41.0m)
Interest Coverage Ratio = 4.22 (Ebit TTM 1.29b / Interest Expense TTM 305.0m)
EV/FCF = 27.37x (Enterprise Value 26.24b / FCF TTM 959.0m)
FCF Yield = 3.65% (FCF TTM 959.0m / Enterprise Value 26.24b)
FCF Margin = 2.43% (FCF TTM 959.0m / Revenue TTM 39.42b)
Net Margin = 1.71% (Net Income TTM 676.0m / Revenue TTM 39.42b)
Gross Margin = 17.41% ((Revenue TTM 39.42b - Cost of Revenue TTM 32.56b) / Revenue TTM)
Gross Margin QoQ = 17.55% (prev 17.20%)
Tobins Q-Ratio = 1.83 (Enterprise Value 26.24b / Total Assets 14.31b)
Interest Expense / Debt = 1.29% (Interest Expense 78.0m / Debt 6.03b)
Taxrate = 24.59% (60.0m / 244.0m)
NOPAT = 969.8m (EBIT 1.29b * (1 - 24.59%))
Current Ratio = 1.16 (Total Current Assets 4.16b / Total Current Liabilities 3.59b)
Debt / Equity = 1.40 (Debt 6.03b / totalStockholderEquity, last quarter 4.31b)
Debt / EBITDA = 3.43 (Net Debt 5.99b / EBITDA 1.75b)
Debt / FCF = 6.25 (Net Debt 5.99b / FCF TTM 959.0m)
Total Stockholder Equity = 4.50b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.87% (Net Income 676.0m / Total Assets 14.31b)
RoE = 15.01% (Net Income TTM 676.0m / Total Stockholder Equity 4.50b)
RoCE = 13.44% (EBIT 1.29b / Capital Employed (Equity 4.50b + L.T.Debt 5.06b))
RoIC = 10.07% (NOPAT 969.8m / Invested Capital 9.63b)
WACC = 7.44% (E(20.25b)/V(26.28b) * Re(9.37%) + D(6.03b)/V(26.28b) * Rd(1.29%) * (1-Tc(0.25)))
Discount Rate = 9.37% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.77%
[DCF] Terminal Value 83.09% ; FCFF base≈908.6m ; Y1≈1.12b ; Y5≈1.91b
[DCF] Fair Price = 137.6 (EV 36.33b - Net Debt 5.99b = Equity 30.34b / Shares 220.5m; r=7.44% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 80.13 | EPS CAGR: 32.70% | SUE: 1.06 | # QB: 3
Revenue Correlation: 87.97 | Revenue CAGR: 6.28% | SUE: -1.46 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.39 | Chg7d=+0.013 | Chg30d=+0.015 | Revisions Net=+7 | Analysts=15
EPS current Year (2026-12-31): EPS=4.78 | Chg7d=+0.071 | Chg30d=+0.071 | Revisions Net=+9 | Growth EPS=+20.0% | Growth Revenue=+5.4%
EPS next Year (2027-12-31): EPS=5.63 | Chg7d=+0.105 | Chg30d=+0.108 | Revisions Net=+9 | Growth EPS=+17.8% | Growth Revenue=+4.1%
[Analyst] Revisions Ratio: +0.54 (10 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.1% (Discount Rate 9.4% - Earnings Yield 3.2%)
[Growth] Growth Spread = -1.9% (Analyst 4.3% - Implied 6.1%)
P/E Forward = 19.0476
P/S = 0.5138
P/B = 4.652
P/EG = 0.2439
Revenue TTM = 39.42b USD
EBIT TTM = 1.29b USD
EBITDA TTM = 1.75b USD
Long Term Debt = 5.06b USD (from longTermDebt, last quarter)
Short Term Debt = 353.0m USD (from shortTermDebt, last quarter)
Debt = 6.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.99b USD (from netDebt column, last quarter)
Enterprise Value = 26.24b USD (20.25b + Debt 6.03b - CCE 41.0m)
Interest Coverage Ratio = 4.22 (Ebit TTM 1.29b / Interest Expense TTM 305.0m)
EV/FCF = 27.37x (Enterprise Value 26.24b / FCF TTM 959.0m)
FCF Yield = 3.65% (FCF TTM 959.0m / Enterprise Value 26.24b)
FCF Margin = 2.43% (FCF TTM 959.0m / Revenue TTM 39.42b)
Net Margin = 1.71% (Net Income TTM 676.0m / Revenue TTM 39.42b)
Gross Margin = 17.41% ((Revenue TTM 39.42b - Cost of Revenue TTM 32.56b) / Revenue TTM)
Gross Margin QoQ = 17.55% (prev 17.20%)
Tobins Q-Ratio = 1.83 (Enterprise Value 26.24b / Total Assets 14.31b)
Interest Expense / Debt = 1.29% (Interest Expense 78.0m / Debt 6.03b)
Taxrate = 24.59% (60.0m / 244.0m)
NOPAT = 969.8m (EBIT 1.29b * (1 - 24.59%))
Current Ratio = 1.16 (Total Current Assets 4.16b / Total Current Liabilities 3.59b)
Debt / Equity = 1.40 (Debt 6.03b / totalStockholderEquity, last quarter 4.31b)
Debt / EBITDA = 3.43 (Net Debt 5.99b / EBITDA 1.75b)
Debt / FCF = 6.25 (Net Debt 5.99b / FCF TTM 959.0m)
Total Stockholder Equity = 4.50b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.87% (Net Income 676.0m / Total Assets 14.31b)
RoE = 15.01% (Net Income TTM 676.0m / Total Stockholder Equity 4.50b)
RoCE = 13.44% (EBIT 1.29b / Capital Employed (Equity 4.50b + L.T.Debt 5.06b))
RoIC = 10.07% (NOPAT 969.8m / Invested Capital 9.63b)
WACC = 7.44% (E(20.25b)/V(26.28b) * Re(9.37%) + D(6.03b)/V(26.28b) * Rd(1.29%) * (1-Tc(0.25)))
Discount Rate = 9.37% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.77%
[DCF] Terminal Value 83.09% ; FCFF base≈908.6m ; Y1≈1.12b ; Y5≈1.91b
[DCF] Fair Price = 137.6 (EV 36.33b - Net Debt 5.99b = Equity 30.34b / Shares 220.5m; r=7.44% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 80.13 | EPS CAGR: 32.70% | SUE: 1.06 | # QB: 3
Revenue Correlation: 87.97 | Revenue CAGR: 6.28% | SUE: -1.46 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.39 | Chg7d=+0.013 | Chg30d=+0.015 | Revisions Net=+7 | Analysts=15
EPS current Year (2026-12-31): EPS=4.78 | Chg7d=+0.071 | Chg30d=+0.071 | Revisions Net=+9 | Growth EPS=+20.0% | Growth Revenue=+5.4%
EPS next Year (2027-12-31): EPS=5.63 | Chg7d=+0.105 | Chg30d=+0.108 | Revisions Net=+9 | Growth EPS=+17.8% | Growth Revenue=+4.1%
[Analyst] Revisions Ratio: +0.54 (10 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.1% (Discount Rate 9.4% - Earnings Yield 3.2%)
[Growth] Growth Spread = -1.9% (Analyst 4.3% - Implied 6.1%)